This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feske, M.
Right arrow Articles by Lewis, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feske, M.
Right arrow Articles by Lewis, D. E.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, October 2008, p. 1616-1622, Vol. 15, No. 10
1071-412X/08/$08.00+0     doi:10.1128/CVI.00185-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Enhancement of Human Antigen-Specific Memory T-Cell Responses by Interleukin-7 May Improve Accuracy in Diagnosing Tuberculosis{triangledown} ,{dagger}

Marsha Feske,1,2,3 Rodolfo J. Nudelman,2 Miguel Medina,2 Justin Lew,3 Manisha Singh,2 Jacob Couturier,2 Edward A. Graviss,3 and Dorothy E. Lewis2*

University of Texas School of Public Health,1 Departments of Immunology,2 Pathology, Baylor College of Medicine, Houston, Texas3

Received 23 May 2008/ Returned for modification 27 June 2008/ Accepted 13 August 2008

Children and immunocompromised adults are at an increased risk of tuberculosis (TB), but diagnosis is more challenging. Recently developed gamma interferon (IFN-{gamma}) release assays provide increased sensitivity and specificity for diagnosis of latent TB, but their use is not FDA approved in immunocompromised or pediatric populations. Both populations have reduced numbers of T cells, which are major producers of IFN-{gamma}. Interleukin 7 (IL-7), a survival cytokine, stabilizes IFN-{gamma} message and increases protein production. IL-7 was added to antigen-stimulated lymphocytes to improve IFN-{gamma} responses as measured by enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot (ELISPOT) assay. Antigens used were tetanus toxoid (n = 10), p24 (from human immunodeficiency virus [HIV], n = 9), and TB peptides (n = 15). Keyhole limpet hemocyanin was used as a negative control, and phytohemagglutinin was the positive control. IL-7 improved antigen-specific responses to all antigens tested including tetanus toxoid, HIV type 1 p24, and TB peptides (ESAT-6 and CFP-10) with up to a 14-fold increase (mean = 3.8), as measured by ELISA. Increased IFN-{gamma} responses from controls, HIV-positive patients, and TB patients were statistically significant, with P values of <0.05, 0.01, and 0.05, respectively. ELISPOT assay results confirmed ELISA findings (P values of <0.01, 0.02, and 0.03, respectively), with a strong correlation between the two tests (R2 = 0.82 to 0.99). Based on average background levels, IL-7 increased detection of IFN-{gamma} by 39% compared to the level with antigen alone. Increased production of IFN-{gamma} induced by IL-7 improves sensitivity of ELISA and ELISPOT assays for all antigens tested. Further enhancement of IFN-{gamma}-based assays might improve TB diagnosis in those populations at highest risk for TB.


* Corresponding author. Mailing address: Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, 301 University Boulevard, Mail Route 0435, Galveston, TX 77555-0567. Phone: (409) 747-0240. Fax: (409) 772-6527. E-mail: dolewis{at}utmb.edu

{triangledown} Published ahead of print on 27 August 2008.

{dagger} Supplemental material for this article may be found at http://cvi.asm.org/.


Clinical and Vaccine Immunology, October 2008, p. 1616-1622, Vol. 15, No. 10
1071-412X/08/$08.00+0     doi:10.1128/CVI.00185-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.